Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-22

Clinical Trial Update: Delirium Reduction With Ramelteon [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is exploring whether ramelteon can reduce delirium, with recruitment ongoing at Centennial Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (Rozerem) (ramelteon)

Snippet

Sponsor: Centennial Medical Center | Conditions: Delirium | Phase 4 | Status: RECRUITING